Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The Valens Company is a leading Canadian cannabis firm specializing in high-quality extraction, product development, and manufacturing of cannabinoid-based products. Originally founded as Valens GroWorks, the company transitioned from cultivation to becoming a premier third-party processor and consumer packaged goods provider. Its diverse portfolio includes cannabis oils, vapes, edibles, and infused beverages, supported by an ISO 17025 accredited laboratory for rigorous testing and quality control. In early 2023, the company was acquired by SNDL Inc., integrating its advanced processing capabilities into one of Canada's largest vertically integrated cannabis operations.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Valens Farms.